Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity
新型CD123×CD33双顺反子嵌合抗原受体（CAR）-T疗法有望减少单靶点CAR-T疗法的逃逸，且不会增加血液毒性。
期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12474
Wang, Zhenzhen; Lu, Yang; Liu, Yu; Mou, Junli; Liu, Xiaoyu; Chen, Manling; Wang, Ying; Xu, Yingxi; Rao, Qing; Xing, Haiyan; Tang, Kejing; Tian, Zheng; Wang, Bing; Qi, Wei; Wang, Min; Qiu, Shaowei; Xiong, Dongsheng; Wang, Jianxiang
